Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant

Kevin K Ariën, Leo Heyndrickx, Johan Michiels, Katleen Vereecken, Kurt Van Lent, Sandra Coppens, Betty Willems, Pieter Pannus, Geert A Martens, Marjan Van Esbroeck, Maria E Goossens, Arnaud Marchant, Koen Bartholomeeusen, Isabelle Desombere

Research output: Contribution to journalA1: Web of Science-article


We report the levels of neutralising antibodies against Wuhan, Delta and Omicron variants in unimmunized infected (group 1), immunised and boosted (group 2) and infected immunised and boosted (group 3) adult individuals. Our observations support the rapid administration of a booster vaccine dose to prevent infection and disease caused by Omicron.

Original languageEnglish
Article number35
Issue number1
Number of pages3
Publication statusPublished - 2022

Cite this